Search

Displaying results 2971 - 2980 of 9702 in total
  1. Drug

    Inixaciclib

    go.drugbank.com/drugs/DB21584
    Experimental

    Inixaciclib has a monoisotopic molecular weight of 480.24 Da. … Inixaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Inixaciclib is a cyclin dependant kinase inhibitor.

  2. Drug

    Culmerciclib

    go.drugbank.com/drugs/DB21600
    Investigational

    Culmerciclib has a monoisotopic molecular weight of 446.23 Da. … Culmerciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Culmerciclib is a cyclin dependant kinase inhibitor.

  3. Drug

    Monzosertib

    go.drugbank.com/drugs/DB21619
    Investigational

    Monzosertib has a monoisotopic molecular weight of 465.16 Da. … Monzosertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Monzosertib is a serine/threonine kinase inhibitor.

  4. Drug

    Votoplam

    go.drugbank.com/drugs/DB21645
    Investigational

    Votoplam is a small molecule drug. The usage of the INN stem '-plam' in the name indicates that Votoplam is a SMN2 gene splicing modulator. Votoplam has a monoisotopic molecular weight of 419.22 Da.

  5. Drug

    Potrasertib

    go.drugbank.com/drugs/DB21682
    Experimental

    Potrasertib has a monoisotopic molecular weight of 564.19 Da. … Potrasertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Potrasertib is a serine/threonine kinase inhibitor.

  6. Drug

    Tigemocoxib

    go.drugbank.com/drugs/DB21699
    Experimental

    Tigemocoxib has a monoisotopic molecular weight of 334.06 Da. … Tigemocoxib is a small molecule drug. The usage of the INN stem '-coxib' in the name indicates that Tigemocoxib is a selective cyclo-oxygenase inhibitor.

  7. Drug

    PRO-1562

    go.drugbank.com/drugs/DB33979
    Experimental

    PRO-1562 is a small molecule drug. … PRO-1562 is under investigation in clinical trial NCT07826689 (A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis).

  8. Drug

    Cantharidin

    go.drugbank.com/drugs/DB12328
    ApprovedInvestigational

    [A32891, A32892] For its natural purpose, the male blister beetle secretes and presents the cantharidin to a female beetle as a copulatory gift during mating. … Available synthetically since the 1950s, topical applications of cantharidin have been used predominantly as a treatment for cutaneous warts since that time.

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Milnacipran

    go.drugbank.com/drugs/DB04896
    ApprovedInvestigational

    Nevertheless, milnacipran demonstrates a somewhat unique characteristic among SNRIs to elicit a relatively balanced reuptake inhibition of both serotonin and noradrenaline, with a somewhat increased preference … Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) and like many agents in this category was originally developed for and continues to be approved and indicated for the treatment

  10. Drug

    Zanubrutinib

    go.drugbank.com/drugs/DB15035
    ApprovedInvestigational

    trial whose tumour is entirely or partially destroyed by a drug. … [A187967] BTK is an enzyme that plays a role in oncogenic signalling pathways, promoting the survival and proliferation of malignant B cells.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index